205 related articles for article (PubMed ID: 34077345)
21. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.
Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM
J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799
[TBL] [Abstract][Full Text] [Related]
22. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
[TBL] [Abstract][Full Text] [Related]
23. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
24. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
Brabletz S; Brabletz T
EMBO Rep; 2010 Sep; 11(9):670-7. PubMed ID: 20706219
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
27. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
Kong D; Li Y; Wang Z; Banerjee S; Ahmad A; Kim HR; Sarkar FH
Stem Cells; 2009 Aug; 27(8):1712-21. PubMed ID: 19544444
[TBL] [Abstract][Full Text] [Related]
28. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
29. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
[TBL] [Abstract][Full Text] [Related]
30. ZEB1-responsive genes in non-small cell lung cancer.
Gemmill RM; Roche J; Potiron VA; Nasarre P; Mitas M; Coldren CD; Helfrich BA; Garrett-Mayer E; Bunn PA; Drabkin HA
Cancer Lett; 2011 Jan; 300(1):66-78. PubMed ID: 20980099
[TBL] [Abstract][Full Text] [Related]
31. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
32. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.
Hill L; Browne G; Tulchinsky E
Int J Cancer; 2013 Feb; 132(4):745-54. PubMed ID: 22753312
[TBL] [Abstract][Full Text] [Related]
33. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
[TBL] [Abstract][Full Text] [Related]
34. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.
Bendoraite A; Knouf EC; Garg KS; Parkin RK; Kroh EM; O'Briant KC; Ventura AP; Godwin AK; Karlan BY; Drescher CW; Urban N; Knudsen BS; Tewari M
Gynecol Oncol; 2010 Jan; 116(1):117-25. PubMed ID: 19854497
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
36. PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.
Xie H; Chen J; Ma Z; Gao Y; Zeng J; Chen Y; Yang Z; Xu S
Prostate; 2024 Mar; 84(4):317-328. PubMed ID: 38145367
[TBL] [Abstract][Full Text] [Related]
37. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
38. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]